HutchMED (China) LIMITED Increase (Decrease) in Operating Capital
HutchMED (China) LIMITED (HCM) reported Increase (Decrease) in Operating Capital of $60.86 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-03-05
- HutchMED (China) LIMITED increase (decrease) in operating capital for the quarter ending 2019-12-31 was -$4.96M, a 191.49% decline year-over-year.
- HutchMED (China) LIMITED increase (decrease) in operating capital for the quarter ending 2019-09-30 was $3.32M.
- HutchMED (China) LIMITED increase (decrease) in operating capital for the quarter ending 2019-06-30 was -$12.70M.
- HutchMED (China) LIMITED increase (decrease) in operating capital for the quarter ending 2019-03-31 was -$1.77M, a 119.30% decline year-over-year.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 6 month as first filed | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $60.86M 20-F · filed 2026-03-05 | ||||
| 2025-06-30 | $52.82M 6-K · filed 2025-08-07 | ||||
| 2024-12-31 | $62.17M 20-F · filed 2026-03-05 | ||||
| 2024-06-30 | $50.46M 6-K · filed 2025-08-07 | ||||
| 2023-12-31 | -$71.15M 20-F · filed 2026-03-05 | ||||
| 2023-06-30 | -$60.63M 6-K · filed 2024-07-31 | ||||
| 2022-12-31 | -$58.70M 20-F · filed 2025-03-19 | ||||
| 2022-06-30 | -$57.78M 6-K · filed 2023-07-31 | ||||
| 2021-12-31 | -$32.46M 20-F · filed 2024-02-28 | ||||
| 2021-06-30 | -$10.99M 6-K · filed 2022-08-01 | ||||
| 2020-12-31 | -$29.27M 20-F · filed 2023-02-28 | ||||
| 2020-06-30 | -$5.56M 6-K · filed 2021-07-28 | ||||
| 2019-12-31 | -$4.96M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$1.64M derived: sum of 2 quarters · filed 2022-03-03 | -$14.34M derived: sum of 3 quarters · filed 2022-03-03 | -$16.11M 20-F · filed 2022-03-03 | |
| 2019-09-30 | $3.32M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$9.38M derived: sum of 2 quarters · filed 2020-07-30 | -$11.15M 6-K · filed 2020-01-21 | -$5.73M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | -$12.70M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | -$14.46M 6-K · filed 2020-07-30 | -$9.05M derived: sum of 3 quarters · filed 2021-03-04 | -$17.64M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | -$1.77M 6-K · filed 2019-06-06 | $3.65M derived: sum of 2 quarters · filed 2021-03-04 | -$4.95M derived: sum of 3 quarters · filed 2021-03-04 | -$18.09M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | $5.42M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$3.18M derived: sum of 2 quarters · filed 2021-03-04 | -$16.32M derived: sum of 3 quarters · filed 2021-03-04 | -$7.16M 20-F · filed 2021-03-04 | |
| 2018-09-30 | -$8.60M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$21.74M derived: sum of 2 quarters · filed 2020-01-21 | -$12.58M 6-K · filed 2020-01-21 | ||
| 2018-06-30 | -$13.14M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -$3.98M 6-K · filed 2019-07-30 | |||
| 2018-03-31 | $9.16M 6-K · filed 2019-06-06 | ||||
| 2017-12-31 | $14.51M 20-F · filed 2020-03-03 | ||||
| 2017-06-30 | $7.08M 6-K · filed 2018-07-27 | -$7.08M 6-K · filed 2017-07-31 | |||
| 2016-12-31 | -$3.43M 20-F · filed 2019-03-11 | ||||
| 2016-06-30 | $7.58M 6-K · filed 2017-07-31 | ||||
| 2015-12-31 | $9.95M 20-F · filed 2018-03-12 |